Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

How to Become a T Follicular Helper Cell

03.08.2015

Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design

Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong and lasting antibody response to viruses and other microbes, have garnered intense interest in recent years but the molecular signals that drive their differentiation had remained unclear. Now, a team of researchers at the La Jolla Institute for Allergy and Immunology has identified a pair of master regulators that control the fate of TFH cells.


Joyce Hu, La Jolla Institute for Allergy and Immunology

Follicular helper T cells (cells with green surface markers) interact closely with B cells (cells with orange surface markers) to facilitate the proliferation of B cells and the production of high affinity antibodies. The interaction site is shown in yellow, DNA in blue. Image: Courtesy of Joyce Hu, La Jolla Institute of Allergy and Immunology.

Their finding, published in this week’s online edition of Nature Immunology, holds great promise for improved vaccine design and may lead to new treatments for immune disorders and possibly even cancer. “Almost all licensed human vaccines work on the basis of inducing a long-term, protective antibody response,” says the study’s lead author Shane Crotty, Ph.D., a professor in the Institute’s Division of Vaccine Discovery. “Being able to enhance or increase the frequency of follicular helper T cells may be an excellent approach for better vaccine design.”

Before B cells can launch a full-blown antibody response against invading pathogens they undergo a tightly orchestrated, multi-step maturation process aided by TFH cells. Often compared to a miniaturized Darwinian struggle for survival, this process selectively promotes the proliferation of B cells that produce high-affinity antibodies and weeds out those that produce less potent ones.

“B cells compete for TFH cells to survive,” explains postdoctoral researcher and first author Youn Soo Choi, Ph.D., “Only those B cells that produce highly specific antibodies attract TFH cells and are able to proliferate.” The survivors undergo successive rounds of mutation and selection resulting in better and better antibodies during the course of an immune response.

“TFH cells are essential for the production of most types of antibodies and defects in TFH function or frequency can have dramatic effects,” says Crotty. “It may be particularly important when antibody targets are difficult to recognize and B cells need to explore a bigger mutational landscape. A better understanding of how these cells are produced could really make a difference in how likely it is that your body manages to make good antibodies against an infection.”

In an earlier study, Crotty’s team had identified the BCL6 gene as a crucial mastermind in the differentiation of TFH cells but important pieces of the puzzles had still been missing. A combination of functional genomics and bioinformatics analysis allowed Choi to narrow the list of potential candidates down to a pair of transcription factors, LEF-1 and TCF-1.

Transcription factors act as master switching by binding to regulatory regions in the genome, where they modulate gene activity. He then confirmed the importance of LEF-1 and TCF-1 for the differentiation of TFH cells with the help of mice genetically engineered to lack the genes encoding either LEF-1 or TCF-1.

“Their activity pre-programs CD4+ T cells to respond to TFH induction signals,” says Choi. “It seems very likely that any perturbation that results in lower levels of these transcription factors could decrease the likelihood that T cells differentiate into TFH cells.”

As a matter of fact, individual differences in the predilection to make more TFH cells could explain why some individuals produce highly efficient antibodies against HIV, while most individuals are unable to mount a potent immune response. “It is very difficult to create high-affinity antibodies for HIV, which are necessary to neutralize virus,” explains Crotty. “Interestingly, it turns out that those individuals that are able to make broadly neutralizing antibodies against HIV, have unusually elevated levels of highly functional memory TFH cells. We speculate that these people may have a genetic bias to produce a really good TFH response but we haven’t identified it yet.”

The research was supported by the La Jolla Institute for Allergy and Immunology, the American Cancer Society (RSG-11-161-01-MPC), and the National Institutes of Health (AI105351, AI112579, AI115149, AI119160, AI113806, AI109976, AI063107 and AI072543).

Full citation: “LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6.” Youn Soo Choi, Jodi A Gullicksrud, Shaojun Xing, Zhouhao Zeng, Qiang Shan, Fengyin Li, Paul E Love, Weiqun Peng, Hai-Hui Xue & Shane Crotty. doi:10.1038/ni.3226

ABOUT LA JOLLA INSTITUTE La Jolla Institute for Allergy and Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading towards its goal: life without disease®.

Contact Information
Gina Kirchweger
Communications Officer
gina@liai.org
Phone: 858-752-6640
Mobile: 858-357-7481

Gina Kirchweger | newswise
Further information:
http://www.liai.org

Further reports about: Allergy B cells Cell HIV Helper Jolla T cells antibody response transcription factors

More articles from Life Sciences:

nachricht Molecular Force Sensors
20.09.2017 | Max-Planck-Institut für Biochemie

nachricht Foster tadpoles trigger parental instinct in poison frogs
20.09.2017 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>